NCT03099122 - A Study of Thymoglobuline® Induction Therapy in Adult Recipients of Donated After Cardiac Death Kidney Transplant | Biotech Hunter

Enrollment

115

Participants

Timeline

Start Date

August 16, 2017

Primary Completion Date

November 12, 2019

Study Completion Date

November 12, 2019

Conditions

End-stage Renal Disease

Interventions

BIOLOGICAL

Rabbit Anti-thymocyte Immunoglobulin

"Pharmaceutical form: creamy-white powder~Route of administration: intravenous"

DRUG

Tacrolimus

"Pharmaceutical form: tablet~Route of administration: oral"

DRUG

Methylprednisolone

"Pharmaceutical form: powder~Route of administration: intravenous"

DRUG

Mycophenolate mofetil

"Pharmaceutical form: capsule~Route of administration: oral"

DRUG

Mycophenolate Na

"Pharmaceutical form: capsule~Route of administration: oral"

DRUG

prednisone

"Pharmaceutical form: tablet~Route of administration: oral"

Trial Locations (1)

CHINA, China